By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2801 Sterling Drive

Hatfield  Pennsylvania  19440  U.S.A.
Phone: 215-996-3002 Fax: 215-996-3070



Company News
Genisphere's 3DNA Drug Delivery Platform Achieves Success In Preclinical Treatment Of Posterior Capsular Opacification (PCO) 3/26/2015 10:19:44 AM
Genisphere Closes $2 Million To Accelerate Development Of Targeted Drug Delivery Platform 9/16/2014 9:14:36 AM
Genisphere Develops a Universal Signal Amplification Process for Lateral Flow Rapid Test Applications 10/7/2013 11:30:41 AM
MultiCell Technologies Inc. (MCET.OB) and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer 8/6/2013 10:11:13 AM
Genisphere Licenses 3DNA Dendrimer Signal Amplification Technology to Chembio Diagnostics, Inc. (CEMI.OB) for Lateral Flow Rapid Test Applications 7/29/2013 9:43:51 AM
Genisphere Expands Partnership With Lankenau Institute for Medical Research to Collaborate on Nanotherapeutics 11/30/2012 11:50:25 AM
Genisphere Adapts 3DNA® Dendrimer Technology to Lateral Flow Point-of-Care Assays 7/17/2012 10:29:38 AM
Affymetrix (Santa Clara, California) (AFFX) Completes Strategic Licensing Agreement with Genisphere for Proprietary MicroRNA Reagents 11/17/2011 7:50:11 AM
Affymetrix (Santa Clara, California) (AFFX) Enables Analysis of Challenging Sample Types Through Exclusive Agreement With Genisphere 11/16/2011 7:32:32 AM
Affymetrix (Santa Clara, California) (AFFX) And Genisphere Launch Best-in-Class Solution for microRNA Expression Research 3/16/2009 9:01:42 AM